Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 872428, 17 pages
http://dx.doi.org/10.1155/2015/872428
Research Article

Schisandrae Fructus Supplementation Ameliorates Sciatic Neurectomy-Induced Muscle Atrophy in Mice

1Research Institute, Bio-Port Korea INC, Marine Bio-Industry Development Center, Busan 619-912, Republic of Korea
2Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, Gyeongsan 712-715, Republic of Korea
3Department of Biochemistry, Dong-eui University College of Korean Medicine, Busan 614-052, Republic of Korea
4Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Republic of Korea
5Anti-Aging Research Center and Blue-Bio Industry RIC, College of Natural Sciences & Human Ecology, Dong-eui University, Busan 614-714, Republic of Korea
6Department of Food and Nutrition, College of Natural Sciences & Human Ecology, Dong-eui University, Busan 614-714, Republic of Korea
7Department of Life Science and Biotechnology, College of Natural Sciences & Human Ecology, Dong-eui University, Busan 614-714, Republic of Korea
8Department of Biochemistry, Busan National University College of Medicine, Yangsan 626-870, Republic of Korea

Received 4 October 2014; Accepted 20 April 2015

Academic Editor: Angel Catalá

Copyright © 2015 Joo Wan Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. V. Brooks and J. A. Faulkner, “Skeletal muscle weakness in old age: underlying mechanisms,” Medicine & Science in Sports & Exercise, vol. 26, no. 4, pp. 432–439, 1994. View at Google Scholar · View at Scopus
  2. E. J. Metter, L. A. Talbot, M. Schrager, and R. Conwit, “Skeletal muscle strength as a predictor of all-cause mortality in healthy men,” The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, vol. 57, no. 10, pp. B359–B365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Bodine, E. Latres, S. Baumhueter et al., “Identification of ubiquitin ligases required for skeletal Muscle Atrophy,” Science, vol. 294, no. 5547, pp. 1704–1708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Glass, “Signaling pathways perturbing muscle mass,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 3, pp. 225–229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Ramírez, T. L. Russo, M. C. Sandoval et al., “Joint inflammation alters gene and protein expression and leads to atrophy in the tibialis anterior muscle in rats,” American Journal of Physical Medicine & Rehabilitation/Association of Academic Physiatrists, vol. 90, no. 11, pp. 930–939, 2011. View at Google Scholar · View at Scopus
  6. R. W. Jackman and S. C. Kandarian, “The molecular basis of skeletal muscle atrophy,” The American Journal of Physiology—Cell Physiology, vol. 287, no. 4, pp. C834–C843, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Schiaffino, K. A. Dyar, S. Ciciliot, B. Blaauw, and M. Sandri, “Mechanisms regulating skeletal muscle growth and atrophy,” The FEBS Journal, vol. 280, no. 17, pp. 4294–4314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Sandri, “Signaling in muscle atrophy and hypertrophy,” Physiology, vol. 23, no. 3, pp. 160–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Bassel-Duby and E. N. Olson, “Signaling pathways in skeletal muscle remodeling,” Annual Review of Biochemistry, vol. 75, pp. 19–37, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Powers, A. N. Kavazis, and J. M. McClung, “Oxidative stress and disuse muscle atrophy,” Journal of Applied Physiology, vol. 102, no. 6, pp. 2389–2397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Arakawa, A. Katada, H. Shigyo et al., “Electrical stimulation prevents apoptosis in denervated skeletal muscle,” NeuroRehabilitation, vol. 27, no. 2, pp. 147–154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-Y. Lim and T. R. Han, “Effect of electromyostimulation on apoptosis-related factors in denervation and reinnervation of rat skeletal muscles,” Muscle & Nerve, vol. 42, no. 3, pp. 422–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Léger, R. Senese, A. W. Al-Khodairy et al., “Atrogin-1, MuRF1, and FoXo, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients,” Muscle & Nerve, vol. 40, no. 1, pp. 69–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Hofer, E. Marzetti, J. Xu et al., “Increased iron content and RNA oxidative damage in skeletal muscle with aging and disuse atrophy,” Experimental Gerontology, vol. 43, no. 6, pp. 563–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Onda, Q. Jiao, Y. Nagano et al., “Acupuncture ameliorated skeletal muscle atrophy induced by hindlimb suspension in mice,” Biochemical and Biophysical Research Communications, vol. 410, no. 3, pp. 434–439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. W. Booth, “Physiologic and biochemical effects of immobilization on muscle,” Clinical Orthopaedics and Related Research, vol. 219, pp. 15–20, 1987. View at Google Scholar · View at Scopus
  17. D. R. Thomas, “Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia,” Clinical Nutrition, vol. 26, no. 4, pp. 389–399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Kawano, J. Tanihata, S. Sato et al., “Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats,” The Journal of Physiological Sciences, vol. 59, no. 5, pp. 383–390, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. A. Connor and U. J. McMahan, “Cell accumulation in the junctional region of denervated muscle,” The Journal of Cell Biology, vol. 104, no. 1, pp. 109–120, 1987. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Dell'Era, L. Coco, R. Ronca, B. Sennino, and M. Presta, “Gene expression profile in fibroblast growth factor 2-transformed endothelial cells,” Oncogene, vol. 21, no. 15, pp. 2433–2440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Murray and N. Robbins, “Cell proliferation in denervated muscle: time course, distribution and relation to disuse,” Neuroscience, vol. 7, no. 7, pp. 1817–1822, 1982. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Murray and N. Robbins, “Cell proliferation in denervated muscle: identity and origin of dividing cells,” Neuroscience, vol. 7, no. 7, pp. 1823–1833, 1982. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Ogawa, T. Nikawa, H. Furochi et al., “Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice,” The American Journal of Physiology—Cell Physiology, vol. 289, no. 3, pp. C697–C707, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Salonen, M. Lehto, H. Kalimo, R. Penttinen, and H. Aro, “Changes in intramuscular collagen and fibronectin in denervation atrophy,” Muscle & Nerve, vol. 8, no. 2, pp. 125–131, 1985. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Panossian and G. Wikman, “Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine,” Journal of Ethnopharmacology, vol. 118, no. 2, pp. 183–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Lu and D.-F. Chen, “Analysis of Schisandra chinensis and Schisandra sphenanthera,” Journal of Chromatography A, vol. 1216, no. 11, pp. 1980–1990, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-H. Ma, L. Yang, Y.-G. Zu, and T.-T. Liu, “Optimization of conditions of solvent-free microwave extraction and study on antioxidant capacity of essential oil from Schisandra chinensis (Turcz.) Baill,” Food Chemistry, vol. 134, no. 4, pp. 2532–2539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. C. J. Liu, S. Q. Zhang, J. S. Zhang, Q. Liang, and D. S. Li, “Chemical composition and antioxidant activity of essential oil from berries of Schisandra chinensis (Turcz.) Baill,” Natural Product Research, vol. 26, no. 23, pp. 2199–2203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Chen, Y. Zhang, Y. Zu, and L. Yang, “Chemical composition and antioxidant activity of the essential oil of Schisandra chinensis fruits,” Natural Product Research, vol. 26, no. 9, pp. 842–849, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Song, J.-Y. Ding, C. Tang, and C.-H. Yin, “Compositions and biological activities of essential oils of Kadsura longepedunculata and Schisandra sphenanthera,” The American Journal of Chinese Medicine, vol. 35, no. 2, pp. 353–364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. H. I. Jang, G. M. Do, H. M. Lee, H. M. Ok, J. Shin, and O. Kwon, “Schisandra chinensis Baillon regulates the gene expression of phase II antioxidant/detoxifying enzymes in hepatic damage induced rats,” Nutrition Research and Practice, vol. 8, no. 3, pp. 272–277, 2014. View at Publisher · View at Google Scholar
  32. S. Park, S. M. Hong, I. S. Ahn, Y. J. Kim, and J. B. Lee, “Huang-Lian-Jie-Du-Tang supplemented with Schisandra chinensisBaill. and Polygonatum odoratum Druce improved glucose tolerance by potentiating insulinotropic actions in islets in 90% pancreatectomized diabetic rats,” Bioscience, Biotechnology and Biochemistry, vol. 73, no. 11, pp. 2384–2392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Zhang, L. L. Shi, and Y. N. Zheng, “Dibenzocyclooctadiene lignans from fructus Schisandrae chinensis improve glucose uptake in vitro,” Natural Product Communications, vol. 5, no. 2, pp. 231–234, 2010. View at Google Scholar · View at Scopus
  34. D. Y. Kwon, D. S. Kim, H. J. Yang, and S. Park, “The lignan-rich fractions of Fructus Schisandrae improve insulin sensitivity via the PPAR-γ pathways in in vitro and in vivo studies,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 455–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Young Park, J. Wook Yun, Y. Whan Choi et al., “Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability,” Hypertension Research, vol. 35, no. 9, pp. 928–934, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-M. Yang, P. S. P. Ip, C.-T. Che, and J. H. K. Yeung, “Relaxant effects of Schisandra chinensis and its major lignans on agonists-induced contraction in guinea pig ileum,” Phytomedicine, vol. 18, no. 13, pp. 1153–1160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Nagpal, P. J. Plant, J. Correa et al., “The ubiquitin ligase Nedd4-1 participates in denervation-induced skeletal muscle atrophy in mice,” PLoS ONE, vol. 7, no. 10, Article ID e46427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. H. J. Ringold, E. Batres, O. Halpern, and E. Necoechea, “Steroids. CV.1 2-Methyl and 2-hydroxymethylene-androstane derivatives,” Journal of the American Chemical Society, vol. 81, no. 2, pp. 427–432, 1959. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Pavlatos, O. Fultz, M. J. Monberg, and A. Vootkur, “Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid,” Clinical Therapeutics, vol. 23, no. 6, pp. 789–801, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Isaacs, K. Loveland, S. Mallu, S. Adams, and R. Wodicka, “The use of anabolic steroids as a strategy in reversing denervation atrophy after delayed nerve repair,” Hand, vol. 6, no. 2, pp. 142–148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Del Rio, A. J. Stewart, and N. Pellegrini, “A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress,” Nutrition, Metabolism & Cardiovascular Diseases, vol. 15, no. 4, pp. 316–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  43. I. S. Jamall and J. C. Smith, “Effects of cadmium on glutathione peroxidase, superoxide dismutase, and lipid peroxidation in the rat heart: a possible mechanism of cadmium cardiotoxicity,” Toxicology and Applied Pharmacology, vol. 80, no. 1, pp. 33–42, 1985. View at Publisher · View at Google Scholar · View at Scopus
  44. H. J. He, G. Y. Wang, Y. Gao, W. H. Ling, Z. W. Yu, and T. R. Jin, “Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice,” World Journal of Diabetes, vol. 3, no. 5, pp. 94–104, 2012. View at Publisher · View at Google Scholar
  45. J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, no. 1, pp. 192–205, 1968. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Aebi, “Catalase,” in Methods in Enzymatic Analysis, H. U. Bergmeyer, Ed., pp. 673–686, Academic Press, New York, NY, USA, 1974. View at Google Scholar
  47. Y. Sun, L. W. Oberley, and Y. Li, “A simple method for clinical assay of superoxide dismutase,” Clinical Chemistry, vol. 34, no. 3, pp. 497–500, 1988. View at Google Scholar · View at Scopus
  48. B. D. Clark, I. Bedrosian, R. Schindler et al., “Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays,” Journal of Applied Physiology, vol. 71, no. 6, pp. 2412–2418, 1991. View at Google Scholar · View at Scopus
  49. G. L. Tipoe, T. M. Leung, E. C. Liong, T. Y. H. Lau, M. L. Fung, and A. A. Nanji, “Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice,” Toxicology, vol. 273, no. 1–3, pp. 45–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. S.-R. Shi, B. Chaiwun, L. Young, R. J. Cote, and C. R. Taylor, “Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections,” The Journal of Histochemistry and Cytochemistry, vol. 41, no. 11, pp. 1599–1604, 1993. View at Publisher · View at Google Scholar · View at Scopus
  51. S. H. Ki, J. H. Yang, S. K. Ku, S. C. Kim, Y. W. Kim, and I. J. Cho, “Red ginseng extract protects against carbon tetrachloride-induced liver fibrosis,” Journal of Ginseng Research, vol. 37, no. 1, pp. 45–53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. H. S. Lee, S. H. Choi, and S. K. Ku, “Regional distribution and relative frequency of gastrointestinal endocrine cells in the ddN mice: an immunohistochemical study,” Anatomia, Histologia, Embryologia, vol. 39, no. 6, pp. 521–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Y. Song, S. K. Ku, H. J. Kim, and J. S. Han, “Low molecular weight fucoidan ameliorating the chronic cisplatin-induced delayed gastrointestinal motility in rats,” Food and Chemical Toxicology, vol. 50, no. 12, pp. 4468–4478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Levene, “Pathological factors influencing excision of tumours in the head and neck. Part I,” Clinical Otolaryngology and Allied Sciences, vol. 6, no. 2, pp. 145–151, 1981. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Ludbrook, “Update: microcomputer statistics packages. A personal review,” Clinical and Experimental Pharmacology and Physiology, vol. 24, no. 3-4, pp. 294–296, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Sala, M. Tarnopolsky, C. Webber, G. Norman, and R. Barr, “Serum creatinine: a surrogate measurement of lean body mass in children with acute lymphoblastic leukemia,” Pediatric Blood & Cancer, vol. 45, no. 1, pp. 16–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. S. A. Stimpson, S. M. Turner, L. G. Clifton et al., “Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-d3) dilution in rats,” Journal of Applied Physiology, vol. 112, no. 11, pp. 1940–1948, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Zhang, J.-J. Huang, Z.-Q. Wang, N. Wang, and Z.-Y. Wu, “Value of muscle enzyme measurement in evaluating different neuromuscular diseases,” Clinica Chimica Acta, vol. 413, no. 3-4, pp. 520–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Choi, H. Park, S. Cho, and M. Lee, “Vitamin D3 supplementation modulates inflammatory responses from the muscle damage induced by high-intensity exercise in SD rats,” Cytokine, vol. 63, no. 1, pp. 27–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. I. Cohen, E. Bogin, A. Chechick, and V. Rzetelny, “Biochemical alterations secondary to disuse atrophy in the rat's serum and limb tissues,” Archives of Orthopaedic and Trauma Surgery, vol. 119, no. 7-8, pp. 410–417, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Comporti, “Lipid peroxidation and cellular damage in toxic liver injury,” Laboratory Investigation, vol. 53, no. 6, pp. 599–623, 1985. View at Google Scholar · View at Scopus
  62. F. Odabasoglu, A. Cakir, H. Suleyman et al., “Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats,” Journal of Ethnopharmacology, vol. 103, no. 1, pp. 59–65, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. K. H. Cheeseman and T. F. Slater, “An introduction to free radical biochemistry,” British Medical Bulletin, vol. 49, no. 3, pp. 481–493, 1993. View at Google Scholar · View at Scopus
  64. M. Gore, R. Fiebig, J. Hollander, C. Leeuwenburgh, H. Ohno, and L. L. Ji, “Endurance training alters antioxidant enzyme gene expression in rat skeletal muscle,” Canadian Journal of Physiology and Pharmacology, vol. 76, no. 12, pp. 1139–1145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Süleyman, E. Cadirci, A. Albayrak et al., “Comparative study on the gastroprotective potential of some antidepressants in indomethacin-induced ulcer in rats,” Chemico-Biological Interactions, vol. 180, no. 2, pp. 318–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. N. Zarkovic, “4-hydroxynonenal as a bioactive marker of pathophysiological processes,” Molecular Aspects of Medicine, vol. 24, no. 4-5, pp. 281–291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. E. E. Dubinina and V. A. Dadali, “Role of 4-hydroxy-trans-2-nonenal in cell functions,” Biochemistry (Moscow), vol. 75, no. 9, pp. 1069–1087, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. L. Smathers, J. J. Galligan, B. J. Stewart, and D. R. Petersen, “Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease,” Chemico-Biological Interactions, vol. 192, no. 1-2, pp. 107–112, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. J.-H. Chen, G. L. Tipoe, E. C. Liong et al., “Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants,” The American Journal of Clinical Nutrition, vol. 80, no. 3, pp. 742–751, 2004. View at Google Scholar · View at Scopus
  70. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Delgado, A. Saborido, and A. Megías, “Prolonged treatment with the anabolic-androgenic steroid stanozolol increases antioxidant defences in rat skeletal muscle,” Journal of Physiology and Biochemistry, vol. 66, no. 1, pp. 63–71, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. Y.-E. Yoo and C.-P. Ko, “Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice,” PLoS ONE, vol. 7, no. 5, Article ID e37258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. G. Nuñez, M. A. Benedict, Y. Hu, and N. Inohara, “Caspases: the proteases of the apoptotic pathway,” Oncogene, vol. 17, no. 25, pp. 3237–3245, 1998. View at Google Scholar · View at Scopus
  74. K. L. Barrett, J. M. Willingham, A. J. Garvin, and M. C. Willingham, “Advances in cytochemical methods for detection of apoptosis,” The Journal of Histochemistry and Cytochemistry, vol. 49, no. 7, pp. 821–832, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. A. D. Dam, A. S. Mitchell, J. W. E. Rush, and J. Quadrilatero, “Elevated skeletal muscle apoptotic signaling following glutathione depletion,” Apoptosis, vol. 17, no. 1, pp. 48–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. Y.-P. Yen, K.-S. Tsai, Y.-W. Chen, C.-F. Huang, R.-S. Yang, and S.-H. Liu, “Arsenic induces apoptosis in myoblasts through a reactive oxygen species-induced endoplasmic reticulum stress and mitochondrial dysfunction pathway,” Archives of Toxicology, vol. 86, no. 6, pp. 923–933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. B. A. Bondesen, S. T. Mills, and G. K. Pavlath, “The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms,” American Journal of Physiology—Cell Physiology, vol. 290, no. 6, pp. C1651–C1659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. K. Matsushima and J. J. Oppenheim, “Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF,” Cytokine, vol. 1, no. 1, pp. 2–13, 1989. View at Publisher · View at Google Scholar · View at Scopus
  79. L. J. Old, “Tumor necrosis factor (TNF),” Science, vol. 230, no. 4726, pp. 630–632, 1985. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Assuma, T. Oates, D. Cochran, S. Amar, and D. T. Graves, “IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis,” The Journal of Immunology, vol. 160, no. 1, pp. 403–409, 1998. View at Google Scholar · View at Scopus
  81. B. J. R. Whittle, C. Varga, A. Berko et al., “Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase,” British Journal of Pharmacology, vol. 153, no. 5, pp. 983–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. D. L. Allen, B. J. Greybeck, A. M. Hanson, A. S. Cleary, and S. F. Lindsay, “Skeletal muscle expression of bone morphogenetic protein-1 and tolloid-like-1 extracellular proteases in different fiber types and in response to unloading, food deprivation and differentiation,” The Journal of Physiological Sciences, vol. 60, no. 5, pp. 343–352, 2010. View at Publisher · View at Google Scholar
  83. M. D. Gomes, S. H. Lecker, R. T. Jagoe, A. Navon, and A. L. Goldberg, “Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 25, pp. 14440–14445, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Cohen, J. J. Brault, S. P. Gygi et al., “During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation,” The Journal of Cell Biology, vol. 185, no. 6, pp. 1083–1095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. R. M. Berne, R. M. Knabb, S. W. Ely, and R. Rubio, “Adenosine in the local regulation of blood flow: a brief overview,” Federation Proceedings, vol. 42, no. 15, pp. 3136–3142, 1983. View at Google Scholar · View at Scopus
  86. S. S. Segal and D. T. Kurjiaka, “Coordination of blood flow control in the resistance vasculature of skeletal muscle,” Medicine & Science in Sports & Exercise, vol. 27, no. 8, pp. 1158–1164, 1995. View at Google Scholar · View at Scopus
  87. P. Hespel and E. A. Richter, “Role of adenosine in regulation of carbohydrate metabolism in contracting muscle,” Advances in Experimental Medicine and Biology, vol. 441, pp. 97–106, 1998. View at Publisher · View at Google Scholar · View at Scopus
  88. J. G. Dobson Jr., R. Rubio, and R. M. Berne, “Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow,” Circulation Research, vol. 29, no. 4, pp. 375–384, 1971. View at Publisher · View at Google Scholar · View at Scopus
  89. L. Vergauwen, P. Hespel, and E. A. Richter, “Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle,” The Journal of Clinical Investigation, vol. 93, no. 3, pp. 974–981, 1994. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Lynge and Y. Hellsten, “Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle,” Acta Physiologica Scandinavica, vol. 169, no. 4, pp. 283–290, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Zheng, R. Wang, E. Zambraski, D. Wu, K. A. Jacobson, and B. T. Liang, “Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 6, pp. H3685–H3691, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. M. J. Caterina, M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, and D. Julius, “The capsaicin receptor: a heat-activated ion channel in the pain pathway,” Nature, vol. 389, no. 6653, pp. 816–824, 1997. View at Publisher · View at Google Scholar · View at Scopus
  93. F. Guilak, H. A. Leddy, and W. Liedtke, “Transient receptor potential vanilloid 4: the sixth sense of the musculoskeletal system?” Annals of the New York Academy of Sciences, vol. 1192, pp. 404–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. F. Mizoguchi, A. Mizuno, T. Hayata et al., “Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss,” Journal of Cellular Physiology, vol. 216, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. N. F. Gonzalez-Cadavid, W. E. Taylor, K. Yarasheski et al., “Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14938–14943, 1998. View at Publisher · View at Google Scholar · View at Scopus
  96. G. Carnac, S. Ricaud, B. Vernus, and A. Bonnieu, “Myostatin: biology and clinical relevance,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 7, pp. 765–770, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. E. Michishita, J. Y. Park, J. M. Burneskis, J. C. Barrett, and I. Horikawa, “Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins,” Molecular Biology of the Cell, vol. 16, no. 10, pp. 4623–4635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. M. C. Haigis and L. P. Guarente, “Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction,” Genes & Development, vol. 20, no. 21, pp. 2913–2921, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. R. Amat, A. Planavila, S. L. Chen, R. Iglesias, M. Giralt, and F. Villarroya, “SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-γ co-activator-1α (PGC-1α) gene in skeletal muscle through the PGC-1α autoregulatory loop and interaction with MyoD,” The Journal of Biological Chemistry, vol. 284, no. 33, pp. 21872–21880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Toledo, S. Busquets, E. Ametller, F. J. López-Soriano, and J. M. Argilés, “Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?” Journal of Cachexia, Sarcopenia and Muscle, vol. 2, no. 1, pp. 57–62, 2011. View at Publisher · View at Google Scholar · View at Scopus